As of January 23, 2025, Vincerx Pharma (VINC) has a market cap of $4.062 million USD. According to our data, Vincerx Pharma is ranked No.9093 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 23, 2025 | $4.06 M |
-57.64%
|
Dec 31, 2024 | $9.59 M |
-77.71%
|
Dec 29, 2023 | $43.03 M |
15.69%
|
Dec 30, 2022 | $37.20 M |
-89.99%
|
Dec 31, 2021 | $0.37 B |
-51.27%
|
Dec 31, 2020 | $0.76 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
ADC Therapeutics
ADCT
|
$0.16 B |
-0.000 M
|
Switzerland
|
Mersana Therapeutics
MRSN
|
$65.16 M |
0.000 M
|
USA
|
Sutro Biopharma
STRO
|
$0.16 B |
-0.000 M
|
USA
|
Zymeworks
ZYME
|
$1.01 B |
-0.000 M
|
Canada
|
BioAtla
BCAB
|
$28.93 M |
0.000 M
|
USA
|
Nektar Therapeutics
NKTR
|
$0.17 B |
0.000 M
|
USA
|
CytomX Therapeutics
CTMX
|
$65.57 M |
0.000 M
|
USA
|
Pieris Pharmaceuticals
PIRS
|
$17.96 M |
0.000 M
|
USA
|
Market Cap | = | VINC Stock Price | * | VINC Shares Outstanding |
= | $0.11 | * | 36.47 M | |
= | $4.06 M |